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Na+ can be stored in muscle and skin without commensurate water accumulation. The aim
of this study was to assess Na+ and H2O in muscle and skin with MRI in acute heart failure
patients before and after diuretic treatment and in a healthy cohort.
Methods
Nine patients (mean age 78 years; range 58–87) and nine age and gender-matched con-
trols were studied. They underwent 23Na/1H-MRI at the calf with a custom-made knee coil.
Patients were studied before and after diuretic therapy. 23Na-MRI gray-scale measure-
ments of Na+-phantoms served to quantify Na+-concentrations. A fat-suppressed inversion
recovery sequence was used to quantify H2O content.
Results
Plasma Na+-levels did not change during therapy. Mean Na+-concentrations in muscle and
skin decreased after furosemide therapy (before therapy: 30.7±6.4 and 43.5±14.5 mmol/L;
after therapy: 24.2±6.1 and 32.2±12.0 mmol/L; p˂0.05 and p˂0.01). Water content measure-
ments did not differ significantly before and after furosemide therapy in muscle (p = 0.17)
and only tended to be reduced in skin (p = 0.06). Na+-concentrations in calf muscle and skin
of patients before and after diuretic therapy were significantly higher than in healthy subjects
(18.3±2.5 and 21.1±2.3 mmol/L).
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Conclusions
23Na-MRI shows accumulation of Na+ in muscle and skin in patients with acute heart failure.
Diuretic treatment can mobilize this Na+-deposition; however, contrary to expectations,
water and Na+-mobilization are poorly correlated.
Introduction
Acute heart failure involves Na+ accumulation (as Cl-) putatively in the extracellular space [1].
We observed that Na+ is deposited in skin and muscle physiologically and more so in hyperten-
sion [2–4]. The Na+ is bound to negatively charged glycosaminoglycans (GAG). A very local
hypertonic (to plasma) increase in Na+ concentrations leads to stimulation of tonicity element
binding protein (TonEBP) transcription factor in monocyte phagocytic system (MPS) cells [5–
7]. TonEBP stimulates vascular endothelial growth factor-C (VEGF-C) production that stimu-
lates lymphatics. An increase in lymph-capillary density regulates this site of Na+ storage. The
relevance of this regulatory system to salt-sensitive hypertension was demonstrated previously
[5–7]. Furthermore, long-term balance studies documented infradian rhythms in Na+ balance
and excretion that are highly consistent with an additional Na+ storage compartment [8]. Car-
cass ashing and atomic absorption spectrometry were used, clearly methods that have no
human application [2–7]. Using sodium (23Na) as a target for molecular (atomic) imaging is
not new [9]. The heart has recently been suggested as a target [10]. Cardiac and other applica-
tions for Na+ magnetic resonance imaging (23Na-MRI) have been reviewed [11–13]. Zaaraoui
et al. showed that the distribution of brain sodium accumulation correlates with disability in
multiple sclerosis [14]. Ouwerkerk et al. found an increased Na+ concentration in malignant
breast tissue [15]. Other studies concerned osteoarthritis [16] and indicated that 23Na-MRI has
the potential to provide insight into muscle physiology [17–23]. Our aim was to determine
whether the Na+ storage depot we described could be visibly reduced after therapy for acute
heart failure. Patients with acute heart failure undergo rapid volume shifts during therapy. We
selected these patients for further study of 23Na-MRI. We hypothesize that the behavior of the
Na+ storage depot could have a long-term influence on outcomes for patients with cardiovas-
cular disease [24].
To test our hypothesis regarding the mobility of Na+ stores, we recruited acute heart failure
patients and normal subjects after we had developed 23Na-MRI for our clinical purpose [25,
26]. We developed a coil for 23Na-MRI utilizing the upper calf as a target that allows skin, skel-
etal muscle, and bone to be investigated. In earlier studies, we validated the utility of this
method in experimental animals and human subjects, including hemodialysis patients [27].
Materials and Methods
Patient recruitment
The internal review board of the University Hospital Erlangen, Germany, approved the study
(Re.-No. 3948). All participants gave their written informed consent. The study was conducted
according to the principles of the Declaration of Helsinki.
Patients with acute heart failure were prospectively recruited from the cardiology service
and the emergency department. We selected patients who were able to give informed consent,
were able to clinically tolerate the procedure, including being supine for 30 min, and whose
physicians cleared them for the study. We were able to match the patients with normal controls
23Na-MRI
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in terms of age and sex. Also obviously excluded were persons with metal implants or claustro-
phobia. From January to September 2012, we included patients who were scheduled to receive
intravenous furosemide, based on their physician’s clinical judgment, and who gave their writ-
ten informed consent. Patients underwent 23Na-MRI immediately before and after the guide-
lines-oriented intravenous furosemide therapy. Normal volunteers were recruited by
advertisement and underwent 23Na-MRI once. All subjects underwent medical examinations
and 23Na-MRI in our clinical research center.
Experimental setup and imaging technique
23Na-MRI for quantitative analysis in man was implemented and the methods were validated
and recently published [25–27]. Na+ content was measured in lower leg muscle and skin (at the
level of the largest circumference) with a custom-made 23Na knee-coil (Stark-Contrast,
Erlangen, Germany) at 3.0 T with a magnetic resonance imaging scanner (Magnetom Verio,
Siemens Healthcare, Erlangen, Germany) before and after diuretic therapy using a gradient
echo 23Na sequence (total acquisition time TA: 3.25 minutes, echo time TE: 2.07 ms, repetition
time TR: 100 ms, flip angle FA: 90°, 32 averages, resolution: 3 x 3 x 30 mm3). The gradient echo
23Na sequence was acquired four times successively.
In parallel, water content was quantified in tissue by 1H-MRI, using a fat-suppressed inver-
sion recovery sequence with spin density contrast (total acquisition time: 6.22 minutes, inver-
sion time TI: 210 ms, echo time TE: 12 ms, repetition time TR: 3000 ms, flip angle FA1/2: 90°/
180°, resolution: 1.5 x 1.5 x 5 mm3), as described by other investigators [8]. A T1-weighted
fast-low-angle-shot (FLASH)-sequence was acquired to depict the anatomy and morphology
of the lower leg. The scanning protocol is shown in Table 1.
Image analysis
An experienced radiologist interpreted the compartments of the lower leg, namely triceps
surae muscle, cutis, and entire lower leg (see Fig 1). The different anatomical regions of interest
were drawn guided by the anatomical image (T1-weighted fast-low-angle-shot (FLASH)-
sequence). To measure the cutis one pixel was marked along the coil surface. The value of the
whole lower leg = grey-values> 2x background noise. The interreader reliability was evaluated





Gradient echo 23Na sequence
(acquired 4 times successively)
Total acquisition
time (TA; min)
0.15 2.08 6.22 3.25
Echo time (TE; ms) 4 2.46 12 2.07
Repetition time (TR;
ms)
8.6 250 3000 100
Inversion time (TI;
ms)
- - 210 -
Flip angle (FA; °) 20 60 90/180 90
Averages 2 2 1 32
Bandwidth (Hz/pixel) 320 310 130 430
Field of view (FoV;
mm)
192 192 192 192
Matrix (pixel) 256 256 128 64
Resolution (mm) 0.75 x
0.75 x 10
0.75 x 0.75 x 5 1.5 x 1.5 x 5 3 x 3 x 30
doi:10.1371/journal.pone.0141336.t001
23Na-MRI
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for 23Na measurements of 2 different probands that were assessed by four readers indepen-
dently. Four tubes containing aqueous solutions with increasing Na+ concentrations (10, 20,
30, and 40 mmol/L NaCl) were positioned in a custom-made device positioned inside the coil
just below the patient’s lower leg (see Fig 1). Gray-scale measurements of the tubes served as
calibration standards for 23Na-MRI of the skeletal muscle and skin by relating intensity to a
concentration in a linear trend analysis. Averaged images of four successively acquired gradient
echo 23Na sequences were used to quantify Na+ concentration. For H2O quantification, the fat-
suppressed inversion recovery sequence was evaluated. The 10 mmol/L NaCl tube served as a
calibration standard for tissue water in a linear trend analysis defining a water content of
approximately 1 liter water per liter volume. Since relative H2O changes were of interest, we
used an arbitrary unit. Image analysis was performed using Image J software (Public Domain,
Developer: Wayne Rasband).
Fig 1. Evaluation of the compartments of the lower leg. The compartments of the lower leg were
determined before (left) and after (right) diuretic therapy by an experienced reader. The different anatomical
regions of interest (ROI) were drawn guided by the anatomical image (lower images, T1-weighted fast-low-
angle-shot (FLASH)-sequence). To measure the cutis one pixel was marked along the coil surface. The value
of the whole lower leg = grey-values > 2 x background noise. Four tubes containing aqueous solutions with
increasing Na+ concentrations (10, 20, 30, and 40 mmol/L NaCl) were positioned in a custom-made device
positioned inside the coil just below the patient’s lower leg. Gray-scale measurements of the tubes served as
calibration standards for 23Na-MRI of the skeletal muscle and skin by relating intensity to a concentration in a
linear trend analysis. For H2O quantification, the 10 mmol/L NaCl tube served as a calibration standard for
tissue water in a linear trend analysis defining a water content of approximately 1 liter water per liter volume.
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We calibrated these techniques in earlier studies. Amputated lower limbs from subjects
undergoing operations because of malignancy or diabetes were measured with 23Na-MRI.
These limbs were desiccated (the difference between wet weight and dry weight was considered
tissue water content) and ashed and measured with atomic absorption spectrometry, allowing
us to show a very close correlation between 23Na-MRI signal and actual Na+ concentrations in
muscle and skin [9, 10].
Statistical analysis
Data are expressed as mean ± SD. Data were checked for normal distribution using the Sha-
piro-Wilk test. Data from 23Na/1H-MRI measurements and characteristics of the study popula-
tion were analyzed by two-tailed student’s t-test for paired (before/after therapy) and unpaired
(patients vs. controls) samples. P-values and confidence intervals (95% confidence level) were
calculated using SPSS software (SPSS Statistics v20, IBM, Armonk, USA). Throughout the
analysis, a two-sided p-value of less than 0.05 was considered statistically significant.
Results
Study population
Nine patients with acute heart failure were recruited (7 men/2 women; mean age 78 years;
range, 58–87 years; mean blood pressure before therapy 125±23/73±14 mmHg, mean blood
pressure after therapy 118±22/72±11 mmHg). The heart failure patients all had dyspnea and
weight gain from their previous state. All patients had evidence of increased filling pressures
based on physical examination, chest roentgenogram, and echocardiography. All had periph-
eral edema. The patients were receiving accepted medical treatment, including renin-angioten-
sin system blockade, beta-adrenergic blockade, and chronic diuretic therapy. All acute heart
failure patients were scheduled to receive intravenous furosemide, based on their physician’s
clinical judgment. The mean NT-proBNP blood level of the patients was 7892.11 ± 9688.10
(range: 682–27511) pg/mL before and 6314.60 ± 6953.22 (range: 824–22550) pg/mL after ther-
apy (p = 0.3). We also recruited nine age- and sex-matched control subjects (7 men/2 women;
mean age, 73 years; range 66–89 years; mean blood pressure 130±10/78±10 mmHg) who did
not have heart failure and who were not ingesting any cardiovascular drugs. They were not
treated with furosemide.
23Na/1H-MRI and plasma Na+
23Na/1H-MRI methodology delivered satisfactory image quality in all examinations. Na+ con-
centrations were estimated based on our earlier findings [24–26]. Mean calculated Na+ concen-
trations by 23Na-MRI in the skeletal muscle and skin of the lower leg significantly decreased
during furosemide diuretic therapy (see Fig 2 Upper). In two patients the Na+ concentration in
the muscle increased during therapy. Na+ concentration before therapy was 30.7 ± 6.4 mmol/L
in skeletal muscle and 43.5 ± 14.5 mmol/L in skin, respectively. After furosemide, Na+ concen-
trations were 24.2 ± 6.1 mmol/L in the skeletal muscle (p< 0.05) and 32.2 ± 12.0 mmol/L in
skin (p< 0.01). Interestingly, water content measurements of muscle and skin did not differ
significantly before and after diuretic therapy (p = 0.17 and p = 0.06) (see Fig 2 Middle).
Box plots of the relative Na+ and H2O changes in muscle, skin, and the whole lower leg are
shown in Fig 2 (Lower). The change of the Na+ concentration in the lower leg highly correlated
with the change of the area of the lower leg (R2 = 0.92) during furosemide therapy deduced
from 1H-MRI estimates (see Fig 3). Mean body weight loss during furosemide therapy was
3.6 ± 2.5 kg (p< 0.01).
23Na-MRI
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The muscle Na+ concentration in patients before and after furosemide therapy was signifi-
cantly higher than those of the healthy controls (18.3 ± 2.5 mmol/L; compared to patients
before furosemide: p< 0.001; compared to patients after furosemide: p< 0.05). The same was
true for skin (21.1 ± 2.3 mmol/L; compared to patients before furosemide: p< 0.01; compared
to patients after furosemide: p< 0.05).
Fig 2. Na+ and H2O in muscle and skin in the lower leg of acute heart failure patients before and after
diuretic treatment and of a healthy cohort. Upper:Mean Na+ concentrations determined by 23Na magnetic
resonance imaging in muscle (A) and skin (B) significantly decreased during furosemide diuretic therapy (p ˂
0.05 and p ˂ 0.01). Mean Na+ concentrations in muscle and skin of the lower leg of patients before and after
therapy for acute heart failure were significantly higher compared to corresponding values of healthy
subjects.Middle:Mean H2O contents determined by
1H magnetic resonance imaging in muscle (A) and skin
(B) did not significantly decrease during furosemide diuretic therapy (p > 0.05). Lower: Box plots show the
relative change ((AT-BT)/BT) of Na+ and H2O during furosemide diuretic therapy determined by magnetic
resonance imaging in muscle (A), skin (B) and the whole lower leg (C) (upper horizontal line of box: 75th
percentile; lower horizontal line of box: 25th percentile; horizontal bar within box: median; box within box:
mean; upper and lower horizontal bar outside box: standard deviation). The asterisks indicate significant
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In contrast, plasma Na+ concentrations in the same patients did not change (138.5 ± 3.0
mmol/L before, 138.1 ± 4.3 mmol/L after, p = 0.6) and did not differ from those of the controls
(138.8 ± 2.0 mmol/L; compared to patients before furosemide: p = 0.8; compared to patients
after furosemide: p = 0.6). Furthermore, repetitive 23Na-MRI measurements of the same cross-
section showed a high intra-method precision with an SD of 1.4% for both muscle and skin tis-
sue (n = 9). Results are shown in Table 2.
23Na/1H-MR images from a 71-year-old patient with acute heart failure before and after
furosemide diuretic therapy as well as representative 23Na/1H-MR images of a healthy 71-year-
old volunteer are shown in Fig 4. A dramatic decrease in 23Na-MRI signal intensity can be
noticed in the muscle and skin tissue, whereas the signal intensity of the 4 phantoms appears
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similar in both studies. Conventional 1H-MRI (fat-suppressed inversion recovery sequence)
accompanying the 23Na-MRI studies allowed quantification of water content.
Interreader reliability
The interreader reliability was evaluated for 23Na measurements of 2 different probands that
were assessed by four readers independently. The standard deviations were 0.06/0.05 for the
muscle, 0.15/0.27 for the skin and 0/0.11 for the whole lower leg (Table 3).
Discussion
The important findings in our study are that 23Na-MRI shows accumulation of Na+ in muscle
and skin in patients with acute heart failure. Diuretic treatment can mobilize this Na+ deposi-
tion. However, the water content of muscle and skin did not differ significantly before and
after diuretic therapy.
Despite the fact that Na+ balance is assigned such an important role in the pathophysiology
of acute heart failure, clinicians can only measure plasma concentrations, urinary Na+ excre-
tion, or inquire about Na+ dietary intake. Visualizing Na+ in the body has not been possible.
23Na-MRI offers the opportunity to determine and measure Na+ deposition in the body. We
show that Na+ can be measured in muscle and skin in patients with acute heart failure, that the
levels in the patients are higher than in matched control subjects, and that the levels can be
reduced with treatment. Although Na+ is also stored in bone, our data shown here and our
Table 2. Demographic data and results.
Patients Control group P-value (confidence interval)
Gender 7 men/2 women 7 men/2 women
Age [years] 78 (range: 58–87) 73 (range: 66–89) 0.254 (-13.86–3.93)
Before Therapy After Therapy
Muscle Na+ [mmol/
L]
30.7 ± 6.4 24.2 ± 6.1 18.3 ± 2.5 BT vs. AT: 0.026 (1.02–12.04); BT vs. C: 0.0001 (-17.32 –(-7.54));
AT vs. C: 0.017 (-10.60 –(-1.22))
Skin Na+ [mmol/L] 43.5± 14.5 32.2 ± 12.0 21.1 ± 2.3 BT vs. AT: 0.008 (3.81–18.80); BT vs. C: 0.002 (-33.55 –(-11.96));
AT vs. C: 0.025 (-20.34 –(-1.75))
Whole lower leg
Na+ [mmol/L]
44.7 ± 15.3 29.9 ± 10.7 18.2 ± 2.5 BT vs. AT: 0.004 (6.20–23.45); BT vs. C: 0.001 (-38.27 –(-14.65));
AT vs. C: 0.011 (-19.93 –(-3.34))
Muscle H2O [AU] 0.52 ± 0.069 0.49 ± 0.050 0.486 ± 0.028 BT vs. AT: 0.168 (-0.02–0.08); BT vs. C: 0.266 (-0.08–0.03); AT
vs. C: 0.955 (-0.04–0.04)
Skin H2O [AU] 0.31 ± 0.12 0.24 ± 0.10 0.14 ± 0.069 BT vs. AT: 0.064 (-0.01–0.15); BT vs. C: 0.002 (-0.27 –(-0.07));
AT vs. C: 0.033 (-0.18 –(-0.01))
Whole lower leg
H2O [AU]
0.453 ± 0.101 0.386 ± 0.091 0.362 ± 0.042 BT vs. AT: 0.019 (0.02–0.12); BT vs. C: 0.030 (-0.17 –(-0.01)); AT
vs. C: 0.487 (-0.10–0.05)
Blood Na+ [mmol/L] 138.48 ± 2.96 138.09 ± 4.31 138.80 ± 2.00 BT vs: AT: 0.621 (-1.35–2.13); BT vs. C: 0.761 (-2.15–2.88); AT
vs. C: 0.642 (-2.71–4.22)
Blood NT-proBNP
[pg/mL]
7892.11 ± 9688.10 6314.60 ± 6953.22 NA BT vs. AT: 0.295 (-1697.69–4852.80)
Body weight [kg] 85.9 ± 15.0 82.3 ± 14.9 82.4 ± 15.9 BT vs. AT: 0.003 (1.66–5.49); BT vs. C: 0.639 (-18.90–11.94); AT
vs. C: 0.989 (-15.27–15.47)
Demographic data, [Na+] and H2O content in the muscle, the skin and the lower leg, Na
+/NT-proBNP blood levels and body weight in patients with acute
heart failure before and after diuretic (furosemide) therapy and on the control group are presented (mean ± SD). P-values (two-tailed student’s t-test) and
confidence intervals (95% confidence level) are shown. BT = before therapy, AT = after therapy, C = controls (healthy subjects). AU = arbitrary unit.
NA = not applicable.
doi:10.1371/journal.pone.0141336.t002
23Na-MRI
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earlier animal studies suggest that Na+ at that site is not very exchangeable and appears to play
a negligible clinical role in patients with acute heart failure.
Another important finding from these observations is that Na+ can be stored non-osmoti-
cally, since the MRI images indicate Na+ accumulation without concomitant water accumula-
tion. Like other researchers, we have shown that Na+ could be bound to GAG in skin [2, 27].
Fig 4. Exemplary 23Na/1H-MRI-images of a patient with acute heart failure before and after diuretic
treatment and of a matched healthy subject. Upper row: 23Na scans (gradient echo 23Na sequence) of a
71-year-old patient before and after heart failure therapy. The amount of Na+ in skin and subcutaneous
tissues, as well as in skeletal muscle was reduced, compared to the 10, 20, 30, and 40 mmol/L NaCl solutions
(below). At far right is a normal 71-year-old control person with little sodium in skin and muscle. Lower row:
The same patient before and after furosemide and the control subject viewed with conventional (1H) MRI (fat-
suppressed inversion recovery (IR) sequence). The salt solutions appear white because of their water
content.
doi:10.1371/journal.pone.0141336.g004
Table 3. Interreader reliability.
Reader SD
1 2 3 4
23Na-MRI proband 1
Triceps surae muscle 16.2 16.1 16.2 16.1 0.06
Whole lower leg 16.0 16.0 16.0 16.0 0
Skin 20.6 20.9 20.9 20.9 0.15
23Na-MRI proband 2
Triceps surae muscle 13.1 13.0 13.1 13.1 0.05
Whole lower leg 13.2 13.2 13.0 13.0 0.11
Skin 13.8 14.1 14.4 14.3 0.27
The interreader reliability was evaluated for 23Na measurements of 2 randomly selected probands which
were assessed by four readers independently. Whole lower leg = grey-values > 2 x background noise.
Skin = region where leg is positioned on the cylindrical phantom holders surface (one pixel-thickness = 3
mm). SD = standard deviation.
doi:10.1371/journal.pone.0141336.t003
23Na-MRI
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We have worked on the molecular mechanisms regulating Na+ deposition in skin. We docu-
mented local hypertonicity, with stimulation of TonEPB and a subsequent regulatory cascade
that permits Na+ clearance from the skin [5–7]. When this clearance network is perturbed, salt
sensitive hypertension results. These mechanisms were not yet investigated in animal models
of heart failure, although such studies obviously should be done.
We are struck by the Na+ deposition in muscle. Our animal studies, in the desoxycorticos-
terone (DOCA) salt hypertension rat model, also indicated increased muscle Na+ concentra-
tions. We have not yet investigated skeletal muscle in terms of Na+ storage, a lapse we intend to
correct. Thus, we do not know about non-osmotic Na+ binding on the surface of skeletal mus-
cle cells or conceivably inside these cells. In boys with Duchenne muscular dystrophy (DMD),
1H-MRI has revealed muscular edema before fatty degeneration. Weber et al. recently used
23Na-MRI to test the hypothesis that the edema is caused by an osmotic effect due to increased
myoplasmic Na+ content rather than inflammation that would lead to extracellular edema
[28]. They found that the DMD patients indeed had increased Na+ concentrations of 38.4 ± 6.8
mmol/L, compared to 25.4 ± 2.1 mmol/L in control subjects. The values that we report here for
acute heart failure are even higher than those observed in the DMD patients. We have not
determined TonEBP in skeletal muscle cells and have not measured intracellular or paracellular
osmolality in this tissue. But since we did not observe muscle swelling, we must conclude that
intracellular adjustments occur to deal with the situation. Na+/K+-ATPase is a ubiquitous
enzyme present in higher eukaryotes responsible for the maintenance of ionic gradients across
the plasma membrane. When intracellular Na+ levels rise, and after the activation of calcium-
related signals, an intracellular Na+-sensing network is alerted that activates the Na+/K+-
ATPase, which then expels the excess Na+ from the cytosol [29]. The sodium-induced kinase-1
(SIK1) is pivotal to that network and should be investigated in light of our findings.
Interestingly, diuretic therapy not only induced volume contraction in these patients
accompanied by symptomatic relief, but also reduced muscle and skin Na+ concentration in
stores. The value decreased in all patients in the skin and in 7 of 9 patients in the muscle,
although the responses were variable. This variability suggests that patients differ in their pro-
pensity to release Na+ from muscle and skin. This patient-specific information could give clini-
cians an improved assessment of Na+ in heart failure patients and therefore might have a
therapeutic implication. Interestingly, reductions in Na+ from stores were not accompanied by
a similar reduction in water from the same sites. This state of affairs underscores the idea that
Na+ was indeed stored non-osmotically, bound to proteoglycans.
In skin, we have shown that Na+ clearance is related to lymph-capillary density, which is in
turn regulated by VEGF-C. A soluble VEGF-C receptor exists, termed soluble fms-like tyrosine
kinase-4 (sFlt-4) [30]. Conceivably, the relationship of VEGF-C to sFlt-4 may influence the
propensity of establishing lymph-capillary density in tissues and thereby influence Na+
removal from stores.
Our short-term study has limitations and suggestions for further work. Our study was nec-
essarily observational and, aside from a single diuretic treatment, not longitudinal. We are also
not able to speculate about any relationship between stores, dietary Na+ intake, or severity of
disease. Furthermore, we used a rather long echo time (TE) of 2.07 ms in the 23Na-MRI
sequence. Since the 23Na T2 signal decays bi-exponentially with a fast component (T2 fast) of
0.5 to 3 ms, it was postulated that pulse sequences to reliably measure signals from sodium
should have an ultra-short echo time of less than 0.5 ms to minimize T2-weighting [31]. Thus,
with the used sequence parameters, the obtained signal may at least be partially influenced by
other factors than sodium ions. However, we previously validated the utility of the applied
23Na-MRI methodology for quantitative analysis of tissue Na+ content in experimental animals
and human subjects [25–27]. There is always a trade-off between the signal-to-noise ratio and
23Na-MRI
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spatial resolution in 23Na MR imaging. The accuracy of measuring Na+ concentration in the
skin might be compromised by partial volume effects considering the in-plane resolution of 3
mm in this study for the gradient echo 23Na-MRI sequence. Therefore, we aimed to always
place the lower legs in the same position (a customized cylindrical contact face was fitted inside
the coil). Hence, the partial volume effects should be identical for different measurements. Fur-
thermore, we demonstrated good precision for noninvasive detection of true differences in tis-
sue Na+ content by 23Na-MRI methodology earlier [24]. We therefore conclude that trials on
the changes of tissue Na+ during therapeutic procedures are possible by 23Na-MRI visualiza-
tion. We are aware of male-female differences in Na+ deposition and could not pursue that
issue here. We have no idea about Na+ stores in other ethnic groups. Nonetheless, we believe
that our observations could give clinicians an improved assessment of Na+ in heart failure
patients. Conceivably, these findings also have a therapeutic implication. For instance, other
strategies such as mineralocorticoid receptor blockade, dietary modifications, or treatments
directed at VEGF-C could be developed that might be more effective at reducing Na+ stores.
Conclusions
23Na-MRI allows a reliable and non-invasive illustration and quantification of sodium concen-
tration and distribution. 23Na-MRI shows accumulation of Na+ in muscle and skin in patients
with acute heart failure. Diuretic treatment can mobilize this Na+ deposition. However, water
content of muscle and skin did not differ significantly before and after diuretic therapy. Our
study is too small and preliminary to show a relationship between Na+ mobilization and thera-
peutic responses; however, we are pursuing that hypothesis. 23Na-MRI enables new insights
into sodium homeostasis that presumably lead to a better pathophysiologic comprehension.
This may result in implications for diagnostic and therapeutic strategies.
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